Charles Schwab's $644B Q4 Filing Tells You Exactly Where 35 Million Retail Accounts Put Their Money: Own-Brand ETFs and Mega-Cap Tech

Charles Schwab manages brokerage accounts for over 35 million individual investors. When those investors buy into Schwab's proprietary index funds, target-date funds, and managed portfolios, the underlying holdings aggregate into one of the most unusual 13F filings in the institutional universe: Schwab Investment Management's $644 billion Q4 2025 report.

What makes it unusual? Only 3,592 positions — the fewest of any filer in the top 10 by AUM. For context, Bank of America has 28,105 positions, BNY Mellon has 33,186, and even smaller Invesco has 23,487. Schwab's concentrated position count reflects a focused product lineup: a few dozen large index funds and ETFs, not thousands of separate accounts.

Own-Brand ETFs: $24 Billion in Schwab Products

The signature feature of Schwab IM's filing is the heavy weighting in proprietary Schwab-branded ETFs. Three products crack the top 15:

• FNDX (Schwab Fundamental U.S. Large Co. Index) at $11.3B — #7 in the portfolio, a fundamentally-weighted alternative to S&P 500 indexing
• FNDF (Schwab Fundamental International Large Co.) at $6.6B — #11, providing international equity exposure through Schwab's lens
• SCHR (Schwab Intermediate-Term U.S. Treasury) at $6.0B — #14, a Treasury bond ETF providing portfolio ballast

Combined, these three Schwab-branded products hold $23.9 billion — more than the Amazon position ($14.8B). This is Main Street money channeled through Schwab's vertically integrated model: create the index fund, distribute it through your brokerage platform, manage the underlying securities, and report the aggregate on your 13F.

The Tech Lineup: Nothing Fancy, Everything Large

Schwab IM's top five is the textbook mega-cap order: NVIDIA ($29.1B), Apple ($27.1B), Microsoft ($24.6B), Amazon ($14.8B), Alphabet ($12.5B). The top-5 concentration is 19.4%, which is moderate — higher than BofA's 12.9% but lower than Northern Trust's 22.4%.

The QoQ changes are remarkably small — almost everything moved less than 1% in share count. This is the hallmark of an index-tracking operation: when the underlying indices don't change their weightings, neither does Schwab. The fund complex isn't making active bets; it's faithfully tracking its benchmarks.

The Alphabet Effect — Even at Schwab

Alphabet's combined weight (GOOGL + GOOG) in Schwab's portfolio increased in Q4, continuing the pattern we've documented across every major institutional filer. The GOOGL shares barely moved (+0.3%), but the GOOG shares were essentially unchanged (-0.1%), and the combined value grew by $5.0B on pure price appreciation. Alphabet is now the 5th largest holding in Schwab's portfolio.

This confirms what we've seen at Fidelity, JPMorgan, Goldman Sachs, and every other filer: the Alphabet build is market-wide, driven by the stock's weight growth in the indices themselves. Schwab's near-zero active adjustment proves the point — even doing nothing resulted in more Alphabet.

Eli Lilly's Quiet Rise

The most notable QoQ change was Eli Lilly, which jumped from $4.3B to $6.2B — a 44% increase in value despite only adding 2.2% more shares. Lilly's stock surged on GLP-1 drug demand (Mounjaro, Zepbound), and Schwab's index funds captured that appreciation automatically. At $6.2B, Lilly is now Schwab's 12th largest holding, having climbed from outside the top 15 in Q3.

This is how index investing amplifies winners: Schwab's funds didn't actively decide to buy Lilly. The stock's market cap grew, its index weight increased, and the funds rebalanced accordingly. The 13F filing simply records the result.

How Schwab Compares to Other Wealth Platforms

Schwab IM occupies a unique niche among the mega-filers:

• vs. Bank of America/Merrill: BofA uses Vanguard ETFs; Schwab uses its own products. BofA is more diversified (28K positions vs. 3.6K).
• vs. Invesco: Invesco blends active and passive; Schwab is overwhelmingly index-driven with minimal active overlay.
• vs. Wells Fargo: Wells uses third-party ETFs (SPY, IVV, IWM); Schwab keeps it in-house.

The vertical integration is the story. Schwab doesn't just distribute investments — it manufactures the products, hosts the accounts, executes the trades, and custodies the assets. The 13F filing is a window into that full-stack model.

What Investors Should Watch

Schwab IM's filing is a proxy for what tens of millions of American retail investors own. The signals for Q1 2026:

• Index tracking dominance: Sub-1% share changes across most positions confirm this is autopilot investing
• Own-brand loyalty: FNDX, FNDF, SCHR growing modestly — Schwab's model portfolios continue channeling flows into proprietary products
• Healthcare momentum: Lilly's surge from outside top 15 to #12 reflects the GLP-1 trade entering index consciousness
• Meta added on weakness: Despite Meta falling 2.7% in value, Schwab added 7.8% more shares — the index rebalance that buys the dip automatically

This is the most boring filing in our series, and that's the point. When 35 million accounts invest through index products, the 13F becomes a snapshot of the market itself. Schwab's $644 billion isn't a bet — it's a mirror.